IBDEI1AS ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22987,1,5,0)
 ;;=5^Oral Aphthae
 ;;^UTILITY(U,$J,358.3,22987,2)
 ;;=^114480
 ;;^UTILITY(U,$J,358.3,22988,0)
 ;;=692.72^^125^1399^44
 ;;^UTILITY(U,$J,358.3,22988,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22988,1,4,0)
 ;;=4^692.72
 ;;^UTILITY(U,$J,358.3,22988,1,5,0)
 ;;=5^Photosensitivity
 ;;^UTILITY(U,$J,358.3,22988,2)
 ;;=^93951
 ;;^UTILITY(U,$J,358.3,22989,0)
 ;;=692.6^^125^1399^46
 ;;^UTILITY(U,$J,358.3,22989,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22989,1,4,0)
 ;;=4^692.6
 ;;^UTILITY(U,$J,358.3,22989,1,5,0)
 ;;=5^Poison Ivy
 ;;^UTILITY(U,$J,358.3,22989,2)
 ;;=^271908
 ;;^UTILITY(U,$J,358.3,22990,0)
 ;;=698.0^^125^1399^62
 ;;^UTILITY(U,$J,358.3,22990,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22990,1,4,0)
 ;;=4^698.0
 ;;^UTILITY(U,$J,358.3,22990,1,5,0)
 ;;=5^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,22990,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,22991,0)
 ;;=698.9^^125^1399^61
 ;;^UTILITY(U,$J,358.3,22991,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22991,1,4,0)
 ;;=4^698.9
 ;;^UTILITY(U,$J,358.3,22991,1,5,0)
 ;;=5^Pruritic Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,22991,2)
 ;;=^123977
 ;;^UTILITY(U,$J,358.3,22992,0)
 ;;=696.1^^125^1399^63
 ;;^UTILITY(U,$J,358.3,22992,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22992,1,4,0)
 ;;=4^696.1
 ;;^UTILITY(U,$J,358.3,22992,1,5,0)
 ;;=5^Psoriasis
 ;;^UTILITY(U,$J,358.3,22992,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,22993,0)
 ;;=287.0^^125^1399^64
 ;;^UTILITY(U,$J,358.3,22993,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22993,1,4,0)
 ;;=4^287.0
 ;;^UTILITY(U,$J,358.3,22993,1,5,0)
 ;;=5^Purpura, Vascular
 ;;^UTILITY(U,$J,358.3,22993,2)
 ;;=^101365
 ;;^UTILITY(U,$J,358.3,22994,0)
 ;;=782.1^^125^1399^65
 ;;^UTILITY(U,$J,358.3,22994,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22994,1,4,0)
 ;;=4^782.1
 ;;^UTILITY(U,$J,358.3,22994,1,5,0)
 ;;=5^Rash NOS
 ;;^UTILITY(U,$J,358.3,22994,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,22995,0)
 ;;=706.2^^125^1399^69
 ;;^UTILITY(U,$J,358.3,22995,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22995,1,4,0)
 ;;=4^706.2
 ;;^UTILITY(U,$J,358.3,22995,1,5,0)
 ;;=5^Sebaceous Cyst
 ;;^UTILITY(U,$J,358.3,22995,2)
 ;;=^41304
 ;;^UTILITY(U,$J,358.3,22996,0)
 ;;=690.10^^125^1399^72
 ;;^UTILITY(U,$J,358.3,22996,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22996,1,4,0)
 ;;=4^690.10
 ;;^UTILITY(U,$J,358.3,22996,1,5,0)
 ;;=5^Seborrheic Dermatitis
 ;;^UTILITY(U,$J,358.3,22996,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,22997,0)
 ;;=702.11^^125^1399^70
 ;;^UTILITY(U,$J,358.3,22997,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22997,1,4,0)
 ;;=4^702.11
 ;;^UTILITY(U,$J,358.3,22997,1,5,0)
 ;;=5^Seborrh Keratosis, Inflammatory
 ;;^UTILITY(U,$J,358.3,22997,2)
 ;;=^303311
 ;;^UTILITY(U,$J,358.3,22998,0)
 ;;=702.19^^125^1399^71
 ;;^UTILITY(U,$J,358.3,22998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22998,1,4,0)
 ;;=4^702.19
 ;;^UTILITY(U,$J,358.3,22998,1,5,0)
 ;;=5^Seborrh Keratosis, Other
 ;;^UTILITY(U,$J,358.3,22998,2)
 ;;=^303312
 ;;^UTILITY(U,$J,358.3,22999,0)
 ;;=686.9^^125^1399^73
 ;;^UTILITY(U,$J,358.3,22999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22999,1,4,0)
 ;;=4^686.9
 ;;^UTILITY(U,$J,358.3,22999,1,5,0)
 ;;=5^Skin Infec, Local Unsp
 ;;^UTILITY(U,$J,358.3,22999,2)
 ;;=^123943
 ;;^UTILITY(U,$J,358.3,23000,0)
 ;;=708.9^^125^1399^86
 ;;^UTILITY(U,$J,358.3,23000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23000,1,4,0)
 ;;=4^708.9
 ;;^UTILITY(U,$J,358.3,23000,1,5,0)
 ;;=5^Urticaria, Unsp
 ;;^UTILITY(U,$J,358.3,23000,2)
 ;;=^124650
 ;;^UTILITY(U,$J,358.3,23001,0)
 ;;=078.10^^125^1399^87
 ;;^UTILITY(U,$J,358.3,23001,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI1AS
